CytomX CTMX Crushes Q1 2026 Estimates EPS 010 Tops Views Pacira BioSciences PCRX Reports Strong Q1 2026 Revenue NA EPS Beats Sea Limited SE Draws Attention as a Top Steve Cohen LargeCap Pick Amid Strong Revenue Growth Sunrun Price Target Raised Modestly but SectorWide Solar Challenges Linger Airtel Priority Plan Reignites Net Neutrality Debate OpenAI Reportedly Nears Confidential IPO Filing Signaling a Landmark Moment for AI Sector Tourism Imbalance Turkish Visitors Surge to Greece as Greek Tourists Shun Turkey Trump Pressures Bank of America JPMorgan Over Alleged AntiConservative Practices Social Security Timing Claim at 62 or Wait for Survivor Benefits at 67 Canadian Horticulture Sector Navigates Tariff Challenges Through Local Sourcing Push CDZIP Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 36 ALOY Q1 2024 Earnings EPS Misses Estimates Sharply Stock Rises on No Revenue Disclosure INKT Q1 2026 Earnings BetterThanExpected Loss Drives 159 Stock Rally IMNN Q1 2026 Earnings Narrowing Losses Beat Street Expectations as Pipeline Progress Continues GoPro Q1 2026 Earnings Deep EPS Miss Raises Concerns Amid Modest Stock Gains Dave Busters PLAY Q1 2026 Earnings Massive EPS Miss Sends Stock Higher KVAC Holds Steady Near Support as Trading Remains Quiet Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes Toll Brothers Builds Momentum TOL Stock Rises 26 Amid Housing Sector Strength Gyre Therapeutics GYRE Declines 31 as Stock Tests Key Support Near 545 Armada Acquisition Corp II Warrants XRPNW Shed 1579 as Price Nears Key Support Vendome Acquisition Corp I VNME Holding Steady at 1017 Amid SPAC Market Stability Google Employee Charged in 12 Million Insider Trading Scheme Using Confidential Data Wells Fargo Q1 2026 Earnings Slight EPS Beat Amid Steady Operating Performance Pinnacle Financial Partners PNFP Holds Near Support Amid Modest Gains Utahs Massive AI Datacenter Approval Sparks Controversy Over Energy and Water Use Dollar Strengthens as Oil Prices Surge and Bond Rout Dampens Risk Appetite Jim Cramer Advises Trimming Positions in Volatile AI Chipmaker Amid Market Uncertainty Could Orbital Drug Manufacturing Finally Become a Reality 170YearOld Luxury Fashion Retailer Quietly Shuts 21 Stores in Strategic Restructuring Cerebras Stock Slips 10 in First Full Trading Day After Strong IPO Debut Fed Dissenters Explain No Votes Citing Disagreement Over RateCut Signal